STAT3 phosphorylation inhibition for treating inflammation and new bone formation in ankylosing spondylitis.

Sungsin JoEun Jeong WonMoon-Ju KimYu Jeong LeeSo-Hee JinPu-Reum ParkHo-Chun SongJahae KimYoo-Duk ChoiJi-Young KimSeung Cheol ShimSung Hoon ChoiYe-Soo ParkTae Jong KimTae-Jong Kim

Published in: Rheumatology (Oxford, England) (2021)

Stat-3p inhibition is a promising treatment for both inflammation and new bone formation in AS.

Keyphrases

ankylosing spondylitis
oxidative stress
rheumatoid arthritis
cell proliferation
disease activity